LIFE Stock Overview
Engages in the research and development of medical sensors for health monitoring in Norway. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 2 more risks
Lifecare AS Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NOK 13.15 |
| 52 Week High | NOK 82.16 |
| 52 Week Low | NOK 11.65 |
| Beta | -3.74 |
| 11 Month Change | -34.25% |
| 3 Month Change | -39.14% |
| 1 Year Change | -73.73% |
| 33 Year Change | -46.71% |
| 5 Year Change | -43.80% |
| Change since IPO | -51.37% |
Recent News & Updates
Shareholder Returns
| LIFE | NO Medical Equipment | NO Market | |
|---|---|---|---|
| 7D | -14.6% | -0.2% | 3.1% |
| 1Y | -73.7% | 10.6% | 3.9% |
Return vs Industry: LIFE underperformed the Norwegian Medical Equipment industry which returned 10.6% over the past year.
Return vs Market: LIFE underperformed the Norwegian Market which returned 3.9% over the past year.
Price Volatility
| LIFE volatility | |
|---|---|
| LIFE Average Weekly Movement | 10.5% |
| Medical Equipment Industry Average Movement | 6.1% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in NO Market | 10.6% |
| 10% least volatile stocks in NO Market | 2.7% |
Stable Share Price: LIFE's share price has been volatile over the past 3 months compared to the Norwegian market.
Volatility Over Time: LIFE's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Norwegian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 32 | Joacim Holter | www.lifecare.no |
Lifecare AS engages in the research and development of medical sensors for health monitoring in Norway. The company develops Sencell, a micro sensor for monitoring glucose levels in patients with diabetes. It manufactures and develops nanostrain biosensors for measuring pressure and temperature in live tissue.
Lifecare AS Fundamentals Summary
| LIFE fundamental statistics | |
|---|---|
| Market cap | NOK 199.75m |
| Earnings (TTM) | -NOK 57.64m |
| Revenue (TTM) | NOK 15.07m |
13.8x
P/S Ratio-3.6x
P/E RatioIs LIFE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LIFE income statement (TTM) | |
|---|---|
| Revenue | NOK 15.07m |
| Cost of Revenue | NOK 0 |
| Gross Profit | NOK 15.07m |
| Other Expenses | NOK 72.72m |
| Earnings | -NOK 57.64m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 20, 2025
| Earnings per share (EPS) | -3.64 |
| Gross Margin | 100.00% |
| Net Profit Margin | -382.43% |
| Debt/Equity Ratio | 0% |
How did LIFE perform over the long term?
See historical performance and comparison